Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-02

Clinical Trial Update: Treating H. Pylori in Parkinson's Patients With Motor Fluctuations [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Helicobacter pylori eradication in Parkinson's disease patients with motor fluctuations was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: Parkinson's Disease, Helicobacter Infections | Phase 3 | Status: TERMINATED | Results posted: 2017-12-02